Investor
F-Prime
Cambridge · United States
F-Prime Capital is a global venture capital firm investing in life sciences, healthcare, and technology sectors.
Stage
Pre-seed–Growth
Sectors
4 sectors
Cheque
Not confirmed
Invests in
4 countries
Sectors
FintechB2B SaaSDeep TechDigital Health
Invests in
North AmericaEuropeAsia-PacificLatin America
About
F-Prime Capital invests in healthcare and technology breakthroughs. The firm focuses on therapeutics, medtech, and healthtech in a stage-agnostic fashion. In the technology sector, the team targets enterprise software, fintech, and frontier tech. They manage over five billion dollars in assets to support global portfolio companies. The seasoned team provides real-world expertise to help companies accelerate their path to scalable growth.
Recent deals
- 2026-10Arboretum LifeSciences, Inc.Series ALed
- 2026-10ArboretumSeries ALed
- 2026-03ImmutrinSeries A
- 2025-10LemonSeries BLed
- 2025-09AmplifyMDSeries B
- 2025-01RhyGazeSeries A
- 2024-11NotabeneSeries B
- 2024-10SPRY TherapeuticsSeries A
- 2024-08Chaos LabsSeries A
- 2023-03Bicara TherapeuticsSeries B
- 2023-03Zus HealthSeries A
- 2022-02Canary TechnologiesSeries ALed